此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Automated Oxygen Titration With the EMILY.AI Device During the Six-Minute Walk Test

2026年11月11日 更新者:Aether Tech S.L.

Functional, Clinical, and Predictive Validation Study of the EMILY AI Device in Patients With Acute and Chronic Respiratory Failure: Exercise Substudy (Six-Minute Walk Test) in Ambulatory Patients

This study evaluates EMILY.AI, an investigational (non-CE-marked) smart oxygen valve that automatically adjusts the oxygen flow delivered to a patient, second by second, according to oxygen saturation (SpO2), heart rate and respiratory rate measured by a pulse oximeter.

Adults with chronic respiratory disease who need oxygen during exertion perform two six-minute walk tests on the same day, 30 minutes apart: one with oxygen adjusted automatically by EMILY.AI and one with a fixed oxygen flow delivered through the same device. The order is randomized and participants do not know which test uses automatic titration.

The study compares the time spent within the target saturation range, desaturation, oxygen use, walking distance, breathlessness and participant preference between the two tests. This substudy is part of clinical investigation FJD-EMILY-23-02, whose other substudies are registered in separate records.

研究概览

详细说明

Background Patients with chronic respiratory disease often desaturate during exertion, and fixed-flow oxygen cannot follow the rapid changes in oxygen demand during walking and recovery. EMILY.AI combines a medical-grade oxygen valve with an edge-computing fuzzy-logic algorithm that sets the oxygen flow every second, with continuous logging of physiological signals and delivered flow.

Design Pilot, pragmatic, single-blind, randomized crossover study at Hospital Universitario Fundación Jiménez Díaz (Madrid, Spain). Each participant performs two supervised six-minute walk tests (6MWT) according to the American Thoracic Society guideline, separated by 30 minutes of rest: one with automatic titration by EMILY.AI and one with a fixed flow set by the physician, delivered through the same device so that the participant cannot tell them apart. The order of the two tests is randomized. Each test includes 6 minutes of walking and 2 minutes of standardized recovery.

Safety The medical team knows the device configuration and supervises the valve throughout each test.

Measurements SpO2, heart rate and respiratory rate are recorded with medical-grade pulse oximeters (Nonin, Masimo or Nihon Kohden models), together with distance walked, Borg dyspnoea score, oxygen delivered and participant-reported comfort, breathlessness and preference.

The protocol FJD-EMILY-23-02 also includes a substudy in the Respiratory Intermediate Care Unit and a substudy in a conventional hospital ward, registered separately.

研究类型

介入性

注册 (估计的)

24

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Alba Naya Prieto, MD
  • 电话号码:+34 915 50 48 00
  • 邮箱:alba.naya@fjd.es

研究联系人备份

  • 姓名:Sarah Beatrice Heili Frades, MD, PhD
  • 电话号码:+34 915 50 48 00
  • 邮箱:SHeili@fjd.es

学习地点

      • Madrid、西班牙、28040
        • 招聘中
        • Hospital Universitario Fundación Jiménez Díaz
        • 接触:
          • Sarah Beatrice Heili Frades Zimmermann MD, PhD
          • 电话号码:+34 915 50 48 00
          • 邮箱:SHeili@fjd.es
        • 接触:
          • Alba Naya Prieto, MD
          • 电话号码:+34 915 50 48 00
          • 邮箱:alba.naya@fjd.es
        • 首席研究员:
          • Sarah Beatrice Heili Frades Zimmermann, MD, PhD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

40年 至 90年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Aged 40 to 90 years with a chronic respiratory disease.
  • Indication for exertional oxygen therapy, defined as SpO2 below 88% during a six-minute walk test and/or resting respiratory failure (PaO2 below 60 mmHg).
  • Able to understand the study and sign informed consent.

Exclusion Criteria:

  • Decompensated acute or chronic disease with severe organ involvement, such as cardiovascular disease.
  • Musculoskeletal or neurological disease preventing stable and safe walking.
  • Comorbidities or treatments that, by intensity or dose, limit performance of the tests or interpretation of the results (such as alcohol use, beta-blockers, or other neurological or psychiatric drugs).
  • Walking limitation preventing the six-minute walk test, or cardiovascular or connective tissue disease limiting accurate transcutaneous pulse oximetry.
  • Pregnancy or breastfeeding (women of childbearing potential require a negative pregnancy test at screening).

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:EMILY.AI first, then fixed flow

First 6MWT with automatic titration by EMILY.AI; after 30 minutes of rest, second 6MWT with fixed-flow oxygen through the same device.

Investigational smart oxygen valve with an embedded fuzzy-logic algorithm that adjusts oxygen flow every second from pulse-oximetry SpO2, heart rate and respiratory rate during walking and recovery. Other names: EMILY.AI Smart Valve

Standard care: constant oxygen flow set by the physician, delivered through the EMILY.AI device in fixed mode so that the participant cannot distinguish it from automatic titration.

实验性的:Fixed flow first, then EMILY.AI

First 6MWT with fixed-flow oxygen through the device; after 30 minutes of rest, second 6MWT with automatic titration by EMILY.AI.

Investigational smart oxygen valve with an embedded fuzzy-logic algorithm that adjusts oxygen flow every second from pulse-oximetry SpO2, heart rate and respiratory rate during walking and recovery. Other names: EMILY.AI Smart Valve

Standard care: constant oxygen flow set by the physician, delivered through the EMILY.AI device in fixed mode so that the participant cannot distinguish it from automatic titration.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Percentage of time with SpO2 within the target range
大体时间:Day 1

Percentage of test time (6 minutes of walking plus 2 minutes of recovery) with SpO2, measured by pulse oximetry, within the predefined target range (88-92%), without delivering oxygen while SpO2 is above the range. Compared between the test with automatic titration by EMILY.AI and the test with fixed flow.

Day 1

次要结果测量

结果测量
措施说明
大体时间
Percentage of test time with SpO2 below 88%
大体时间:Day 1

Percentage of test time (walking and recovery) with SpO2 below 88%, compared between conditions.

Day 1
Number of desaturation episodes with SpO2 below 88%
大体时间:Day 1

Number of episodes per test in which SpO2 falls below 88%, compared between conditions.

Day 1
Time to start of oxygen flow correction
大体时间:Day 1

Time in seconds from SpO2 leaving the target range (88-96%) to the start of an oxygen flow change, compared between conditions.

Day 1
Time to return of SpO2 to the target range
大体时间:Day 1

Time in seconds from SpO2 leaving the target range (88-96%) to its return to the range, compared between conditions.

Day 1
Percentage of test time with oxygen delivered while SpO2 is above 92%
大体时间:Day 1

Percentage of test time (walking and recovery) during which oxygen is delivered while SpO2 is above 92%, compared between conditions.

Day 1
Number of episodes with oxygen delivered while SpO2 is above 92%
大体时间:Day 1

Number of episodes per test in which oxygen is delivered while SpO2 is above 92%, compared between conditions.

Day 1
Total oxygen delivered
大体时间:Day 1

Total volume of oxygen delivered (litres) during each test including recovery, compared between conditions.

Day 1
Mean oxygen flow
大体时间:Day 1

Mean oxygen flow (litres per minute) delivered during each test including recovery, compared between conditions.

Day 1
Six-minute walk distance
大体时间:Day 1

Distance walked (metres), compared between conditions.

Day 1
Change in dyspnoea measured with the modified Borg Dyspnoea Scale
大体时间:Day 1: before and immediately after each six-minute walk test

Change from the start to the end of each test in dyspnoea measured with the modified Borg Dyspnoea Scale, which ranges from 0 (no breathlessness at all) to 10 (maximal breathlessness). Higher scores mean a worse outcome. Compared between conditions.

Day 1: before and immediately after each six-minute walk test
Maximum heart rate
大体时间:Day 1

Maximum heart rate (beats per minute) during each test, compared between conditions.

Day 1
Maximum respiratory rate
大体时间:Day 1

Maximum respiratory rate (breaths per minute) during each test, compared between conditions.

Day 1
Perceived difference in exercise capacity between the two tests
大体时间:Day 1: within 1 hour after the second six-minute walk test

Number of participants answering no, partially or yes to the question "Did you notice differences in your exercise capacity in either of the two tests?", and, if so, in which test. Categorical 3-option response, not a scored scale.

Day 1: within 1 hour after the second six-minute walk test
Perceived difference in breathlessness between the two tests
大体时间:Day 1: within 1 hour after the second six-minute walk test

Number of participants answering no, partially or yes to the question "Did you notice differences in shortness of breath in either of the two tests?", and, if so, in which test. Categorical 3-option response, not a scored scale.

Day 1: within 1 hour after the second six-minute walk test
Perceived difference in comfort of oxygen delivery between the two tests
大体时间:Day 1: within 1 hour after the second six-minute walk test

Number of participants answering no, partially or yes to the question "Did you notice differences in the comfort of oxygen delivery in either of the two tests?", and, if so, in which test. Categorical 3-option response, not a scored scale.

Day 1: within 1 hour after the second six-minute walk test
Preference between the two oxygen delivery systems
大体时间:Day 1: within 1 hour after the second six-minute walk test

Number of participants answering no, partially or yes to the question "Do you prefer either of the two oxygen systems used in the tests?", and, if so, which one. Categorical 3-option response, not a scored scale.

Day 1: within 1 hour after the second six-minute walk test
Preference for continuous automatic flow regulation at home
大体时间:Day 1: within 1 hour after the second six-minute walk test

Number of participants answering no, partially or yes to the question "Would you prefer your home oxygen system to regulate the oxygen flow continuously?". Categorical 3-option response, not a scored scale.

Day 1: within 1 hour after the second six-minute walk test
Preference for telemonitored home oxygen
大体时间:Day 1: within 1 hour after the second six-minute walk test

Number of participants answering no, partially or yes to the question "Would you prefer your home oxygen system to be telemonitored by the medical team?". Categorical 3-option response, not a scored scale.

Day 1: within 1 hour after the second six-minute walk test

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Sarah Beatrice Heili Frades, MD, PhD, MD, PhD、Hospital Universitario Fundación Jiménez Díaz

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年4月15日

初级完成 (估计的)

2026年12月20日

研究完成 (估计的)

2026年12月20日

研究注册日期

首次提交

2026年10月28日

首先提交符合 QC 标准的

2026年11月11日

首次发布 (实际的)

2026年11月16日

研究记录更新

最后更新发布 (实际的)

2026年11月16日

上次提交的符合 QC 标准的更新

2026年11月11日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅